Screening for Klinefelter syndrome by invasive diagnostics, requiring amniocentesis or chorionic villus sampling, carries a high risk of miscarriage and fetal malformations. NIPT fetal DNA testing in maternal blood is a new, safe diagnostic method and an effective prenatal screening option for Klinefelter syndrome.

Measuring nuchal translucency is a necessary and very important task in monitoring the development of the fetus. Usually in the 11th-14th week of pregnancy, the pregnant mother will be instructed by the doctor to measure nuchal translucency. Based on the results of the nuchal translucency measurement, the doctor will make a diagnosis of the condition of the fetus. If the results are abnormal,

Performing blood type, Rh factor, blood count tests... helps screen and detect genetic diseases related to blood in mother and fetus. Blood tests during pregnancy are mandatory for pregnant women.